Raymond James Financial’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Buy
512,254
+183,466
+56% +$5.92M ﹤0.01% 1718
2026
Q1
$8.08M Buy
328,788
+233,370
+245% +$5.55M ﹤0.01% 2199
2025
Q4
$1.8M Buy
95,418
+416
+0.4% +$6.91K ﹤0.01% 3359
2025
Q3
$1.41M Sell
95,002
-1,955
-2% -$28K ﹤0.01% 3439
2025
Q2
$1.29M Buy
96,957
+50,592
+109% +$568K ﹤0.01% 3401
2025
Q1
$468K Buy
46,365
+25,671
+124% +$273K ﹤0.01% 3971
2024
Q4
$213K Buy
+20,694
New +$254K ﹤0.01% 4375

Other funds holding CSTM

Raymond James Financial's CSTM Position: Q2 2026 in Review

Raymond James Financial increased its Constellium (CSTM) stake by 56% in Q2 2026, buying an estimated $5.92M and bringing the position to 512,254 shares worth $16.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Raymond James Financial first reported a position in CSTM in Q4 2024 and has held it in 7 quarters since. 389 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Raymond James Financial held 512,254 shares of Constellium worth $16.3M as of Q2 2026.
  • Raymond James Financial bought 183,466 Constellium shares in Q2 2026, an estimated $5.92M.
  • Constellium made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1718 holding.
  • Raymond James Financial first reported a position in Constellium in Q4 2024 and has held it in 7 quarters since.
  • 389 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.